Search Results - "MEEKS, S. L."

Dosimetric evaluation of a novel polymer gel dosimeter for proton therapy by Zeidan, O. A., Sriprisan, S. I., Lopatiuk-Tirpak, O., Kupelian, P. A., Meeks, S. L., Hsi, W. C., Li, Z., Palta, J. R., Maryanski, M. J.

“…Purpose: The aim of this study is to evaluate the dosimetric performance of a newly developed proton-sensitive polymer gel formulation for proton therapy…”
Get full text

Abnormalities of prothrombin: a review of the pathophysiology, diagnosis, and treatment by MEEKS, S. L., ABSHIRE, T. C.

“…Prothrombin (factor II) deficiency is a rare autosomal recessive coagulation disorder that occurs in approximately 1 in 1–2 million people. Prothrombin is…”
Get full text

The use of megavoltage CT (MVCT) images for dose recomputations by Langen, K M, Meeks, S L, Poole, D O, Wagner, T H, Willoughby, T R, Kupelian, P A, Ruchala, K J, Haimerl, J, Olivera, G H

“…Megavoltage CT (MVCT) images of patients are acquired daily on a helical tomotherapy unit (TomoTherapy, Inc., Madison, WI). While these images are used…”
Get more information

Direct Response to Proton Beam Linear Energy Transfer (LET) in a Novel Polymer Gel Dosimeter Formulation by Lopatiuk-Tirpak, O., Su, Z., Li, Z., Zeidan, O. A., Meeks, S. L., Maryanski, M. J.

“…Linear energy transfer (LET) of clinical proton beams is an important parameter influencing the biological effects of radiation. This work demonstrates…”
Get full text

Analysis of risk factors associated with radiosurgery for vestibular schwannoma by FOOTE, Kelly D, FRIEDMAN, William A, BUATTI, John M, MEEKS, Sanford L, BOVA, Frank J, KUBILIS, Paul S

“…The aim of this study was to identify factors associated with delayed cranial neuropathy following radiosurgery for vestibular schwannoma (VS or acoustic…”
Get full text

A Spatial Resolution Study of a New Optical Tomography-Based Polymer Gel Dosimetry System by Sriprisan, S. I., Lopatiuk-Tirpak, O., Meeks, S. L., Zeidan, O. A.

“…A spatial resolution investigation of the OCTOPUS™-IQ scanner in combination with the new BANG3-Pro2® polymer gel was performed by scanning a high-contrast…”
Get full text

US Guidelines for immune tolerance induction in patients with haemophilia a and inhibitors by Valentino, L. A., Kempton, C. L., Kruse-Jarres, R., Mathew, P., Meeks, S. L., Reiss, U. M.

“…Introduction The development of anti‐factor VIII (FVIII) antibodies (inhibitors) is the most serious treatment‐related complication in patients with hemophilia…”
Get full text

Evaluation of a diode array for QA measurements on a helical tomotherapy unit by Langen, K. M., Meeks, S. L., Poole, D. O., Wagner, T. H., Willoughby, T. R., Zeidan, O. A., Kupelian, P. A., Ruchala, K. J., Olivera, G. H.

“…A helical tomotherapy system is used in our clinic to deliver intensity-modulated radiation therapy (IMRT) treatments. Since this machine is designed to…”
Get full text

Anti‐C1 domain antibodies that accelerate factor VIII clearance contribute to antibody pathogenicity in a murine hemophilia A model by Batsuli, G., Ito, J., Mercer, R., Baldwin, W. H., Cox, C., Parker, E. T., Healey, J. F., Lollar, P., Meeks, S. L.

“…Essentials Inhibitor formation remains a challenging complication of hemophilia A care. The Bethesda assay is the primary method used for determining bleeding…”
Get full text

Potential clinical efficacy of intensity-modulated conformal therapy by Meeks, S L, Buatti, J M, Bova, F J, Friedman, W A, Mendenhall, W M, Zlotecki, R A

“…The purpose of this study was to examine the potential benefit of using intensity-modulated conformal therapy for a variety of lesions currently treated with…”
Get more information

Proton vs Hyperarc™ radiosurgery: A planning comparison by Boczkowski, A., Kelly, P., Meeks, S. L., Erhart, K., Bova, F. J., Willoughby, T. R.

“…For many patients, stereotactic radiosurgery (SRS) offers a minimally invasive, curative option when surgical techniques are not possible. To date, the…”
Get full text

Innovating immune tolerance induction for haemophilia by Batsuli, G., Meeks, S. L., Herzog, R. W., Lacroix-Desmazes, S.

“…Introduction Haemophilia A is an X‐linked bleeding disorder characterized by a deficiency of coagulation protein factor VIII (FVIII). A challenging…”
Get full text

Epitope mapping of inhibitory antibodies targeting the C2 domain of coagulation factor VIII by hydrogen–deuterium exchange mass spectrometry by Sevy, A. M., Healey, J. F., Deng, W., Spiegel, P. C., Meeks, S. L., Li, R.

“…Summary Background The development of anti‐factor VIII antibodies (inhibitors) is a significant complication in the management of patients with hemophilia A,…”
Get full text

Expanding the ortholog approach for hemophilia treatment complicated by factor VIII inhibitors by Zakas, P. M., Vanijcharoenkarn, K., Markovitz, R. C., Meeks, S. L., Doering, C. B.

“…Summary Background The formation of neutralizing antibodies (inhibitors) directed against human coagulation factor VIII (hFVIII) is a life‐threatening…”
Get full text

The prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures prior to FVIII inhibitor development by Reipert, B.M., Gangadharan, B., Hofbauer, C.J., Berg, V., Schweiger, H., Bowen, J., Blatny, J., Fijnvandraat, K., Mullins, E.S., Klintman, J., Male, C., McGuinn, C., Meeks, S.L., Radulescu, V.C., Ragni, M.V., Recht, M., Shapiro, A.D., Staber, J.M., Yaish, H.M., Santagostino, E., Brown, D.L.

“…Preventing factor VIII (FVIII) inhibitors following replacement therapies with FVIII products in patients with hemophilia A remains an unmet medical need…”
Get full text

Image localization for frameless stereotactic radiotherapy by Meeks, S L, Bova, F J, Wagner, T H, Buatti, J M, Friedman, W A, Foote, K D

“…Infrared light-emitting diodes (IRLEDs) have been used for optic-guided stereotactic radiotherapy localization at the University of Florida since 1995. The…”
Get more information

Characterization of a genetically engineered mouse model of hemophilia A with complete deletion of the F8 gene by Chao, B. N., Baldwin, W. H., Healey, J. F., Parker, E. T., Shafer‐Weaver, K., Cox, C., Jiang, P., Kanellopoulou, C., Lollar, P., Meeks, S. L., Lenardo, M. J.

“…Essentials Anti‐factor VIII (FVIII) inhibitory antibody formation is a severe complication in hemophilia A therapy. We genetically engineered and characterized…”
Get full text

Design and characterization of a prototype tertiary device for proton beam stereotactic radiosurgery by Willoughby, T R, Boczkowski, A, Meeks, S L, Bova, F J, Zeidan, O A, Erhart, K, Kelly, P

“…Though potentially beneficial, proton beam stereotactic radiosurgery has not been adopted widely secondary to the technical challenge of safely delivering…”
Get more information

Late immune tolerance induction in haemophilia A patients by Meeks, S. L., Chapman, R. L., Kempton, C., Dunn, A. L.

“…Summary The incidence of inhibitor development in patients with severe haemophilia A is approximately 30%. Immune tolerance induction (ITI) is commonly…”
Get full text

The effect of temporal HU variations on the uncertainty of dose recalculations performed on MVCT images by Pukala, J, Meeks, S L, Bova, F J, Langen, K M

“…Over the course of radiation therapy, a patient's anatomy may change substantially. The relatively recent addition of frequent in-room imaging to assist with…”
Get more information